KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index

Q2 2026 earnings release and conference call on August 18, 2026, with medium importance estimated due to typical market volatility following results, scheduled.

Q2 2026 earnings release scheduled.

The Cigna Group is scheduled to release its Q2 2026 financial results before the market opens on July 30, 2026, scheduled. Expected price impact of ~5% based on historical earnings volatility.

Q2 2026 earnings release and conference call scheduled.

Q4 and full-year fiscal 2026 earnings release on 2026-07-29; low impact due to routine scheduling announcement scheduled.

Illinois Tool Works is scheduled to release its Q2 2026 earnings on July 29, 2026, with analysts forecasting EPS of approximately $2.79. This routine announcement is estimated to have a Low importance (>=1% impact), scheduled.

Q4 2026 and full fiscal year earnings results, for which low importance is estimated pending the actual release, are scheduled.

Importance is estimated as Low as market impact will occur upon release; Q2 2026 earnings release scheduled.

Q2 2026 earnings release is scheduled.

Q2 2026 earnings release is scheduled. A 5% price impact is estimated based on historical volatility scheduled.

Q2 2026 earnings release for 2026-07-24 is scheduled. Analysts forecast EPS of approximately $1.07-$1.08. As the estimate aligns with historical growth, low impact is forecasted.

Comcast is scheduled to announce its financial results for the second quarter of 2026 on July 23, 2026, scheduled. Earnings releases typically result in significant price volatility, justifying a Medium importance estimate.

Texas Instruments is scheduled to announce its second quarter 2026 financial results after market close on July 22, 2026, scheduled. Earnings releases are estimated to result in a price impact of 10% or more.

Q2 2026 earnings release and conference call scheduled.

Regions Financial is expected to announce its Q2 2026 earnings results on July 17, 2026, before the market opens; earnings releases typically cause significant price volatility of 5% or more, scheduled.

Bank OZK's Q2 2026 earnings release is scheduled on 2026-07-16; a market reaction of at least 5% is estimated if results deviate from analyst expectations, scheduled.

Q2 2026 earnings release, low importance estimated as a routine announcement; scheduled.

State Street Corporation Q2 2026 financial results and conference call for 2026-07-16. Low importance estimated as earnings typically impact price by at least 1% scheduled.

UnitedHealth Group announced it will release its second quarter 2026 financial results on July 16, 2026, scheduled. Estimated <1% price impact for a routine scheduling announcement.

PepsiCo is scheduled to release its Q2 2026 financial results on July 9, 2026. A medium impact is estimated as quarterly earnings reports typically drive price movements exceeding 5%, scheduled.

Effective July 1, 2026, CEO David M. Cordani will retire and transition to the role of Executive Chair, succeeded by Brian Evanko, scheduled. Estimated price impact <5% as this is a planned leadership transition.

Comcast declared a quarterly cash dividend of $0.33 per share, with an ex-dividend date of July 1, 2026, and a payment date of July 22, 2026.

Q3 2026 earnings results and conference call scheduled; analysts forecast an EPS of approximately $1.25 estimated.

Ex-dividend date on 2026-07-01 for the declared quarterly cash dividend of $0.84 per share. The dividend was announced on 2026-05-20 and is payable on 2026-07-13. Low importance estimated as dividend adjustments typically result in minor price changes scheduled.

NIKE, Inc. is scheduled to release its fourth quarter fiscal 2026 financial results on June 30, 2026, after the market closes. Analysts forecast an EPS of $0.14 and revenue of $10.87 billion, a 2.03% decline year-over-year. High importance is estimated as earnings reports for major consumer brands often trigger price swings exceeding 10%, scheduled.

Ex-dividend date for the Q2 2026 declared cash dividend of $1.61 per share on June 30, 2026. The dividend is payable on July 10, 2026. This is estimated to have a Low importance (>=1% impact) based on the dividend amount, scheduled.

Darden Restaurants is scheduled to release its fiscal 2026 fourth quarter and full year financial results on June 25, 2026, with a conference call at 8:30 a.m. ET; importance is estimated as High due to potential market reaction to full-year results and guidance scheduled

Qualcomm is scheduled to host its 2026 Investor Day on June 24, 2026, where management is expected to detail its strategy for growth and diversification, with a focus on AI and data centers; high importance is estimated due to the potential for significant strategic shifts scheduled.

Paychex is scheduled to release its fourth-quarter and full-year fiscal 2026 financial results on June 24, 2026. Analysts forecast EPS of $1.31-$1.32 estimated. A price impact of ~5% is estimated based on historical earnings volatility. Scheduled.

The ex-dividend date for a regular quarterly cash dividend of $0.96 per common share, payable on July 9, 2026, is scheduled for June 18, 2026. A low price impact is estimated due to the dividend adjustment, and the event is scheduled.

Quarterly dividend ex-date of $0.53 per share on June 15, 2026, announced on April 30, 2026.

Quarterly dividend ex-date of $1.30 per share on June 15, 2026, declared on May 7, 2026.

The company's quarterly dividend of $2.32 per share, a 5% increase, has an ex-dividend date of June 15, 2026. Estimated 1-2% price impact following standard dividend increase announcement.

Quarterly dividend ex-date for a payment of $1.70 per share on 2026-06-12, with payment on July 1, 2026; low impact due to routine nature of dividends scheduled.

Quarterly dividend of $1.25 per share went ex-dividend on June 12, 2026.

Quarterly dividend ex-date on 2026-06-12 for a payment of $0.40 per share, payable on June 26, 2026. A 1% price impact is estimated due to the dividend adjustment scheduled.

Quarterly dividend ex-date of $0.525 per share on 2026-06-12. The dividend is payable on June 29, 2026.

Takeda announced its experimental drug zasocitinib was superior to BMY's Sotyktu in a Phase 3 trial for treating moderate-to-severe plaque psoriasis. Takeda plans to seek regulatory approval in its 2026 fiscal year.

Merck Animal Health announced a definitive agreement to acquire TARGAN on 2026-06-11; importance is estimated at Medium as it expands the animal health portfolio in a niche market, expected.

Comcast Business announced the nationwide launch of SecurityEdge™ Preferred, an AI-powered cybersecurity solution for small businesses, on June 11, 2026.

An insider sold shares worth approximately $8 million, as reported in an SEC filing on June 11, 2026.

Released its annual Human Rights Due Diligence and Modern Slavery report, detailing progress in preventing human rights risks. The report highlighted achieving nearly 100% Child Labor Monitoring and Remediation Systems (CLMRS) coverage in its West Africa Cocoa Life communities.

Target's board of directors announced a 1.8% increase in the quarterly dividend to $1.16 per share on June 11, 2026, with payment scheduled for September 1, 2026; this modest adjustment is estimated to have a price impact of ≥1% and is scheduled.

On June 10, 2026, RBC Capital downgraded Nike's stock from 'Outperform' to 'Sector Perform' and cut its price target to $50, citing a slower-than-expected turnaround. UBS also lowered its price target to $50.

Quarterly dividend ex-date of $0.59 per share on June 10, 2026. The dividend is payable on June 26, 2026. This routine corporate action is estimated to have a low price impact of ≥1%; scheduled.

Reported assets under management (AUM) of $1.89 trillion for May 2026, with net inflows of $3.3 billion.

KeyBanc upgraded MSC Industrial to Overweight from Sector Weight and set a new price target of $117, citing confidence in the company's cost-reduction initiatives following meetings with the new CEO. The stock reached an all-time high of $118.74 on the same day.

Merck and partner Gilead Sciences announced they are halting the Phase 3 EVOKE-03 trial on 2026-06-09; importance is estimated at Medium due to high expectations for Keytruda combination therapies, expected.

Declared a quarterly dividend of $1.30 per share, payable on June 25, 2026, with an ex-dividend date of June 9, 2026.

Launched a major joint marketing campaign with Adidas for the FIFA World Cup 2026, titled "Where It All Kicks Off", featuring prominent athletes.

On June 9, 2026, Texas Instruments introduced a new battery monitor chip (BQ79826Z-Q1) with integrated electrochemical impedance spectroscopy (EIS) for electric vehicles (EVs) and energy storage systems. This product launch is estimated to have a price impact of 1% or more.

Merck and Gilead announced positive topline results from two Phase 3 studies for an oral HIV treatment on 2026-06-08; importance is estimated at Medium as it strengthens the long-term virology pipeline, expected.

Announced a multi-year restructuring plan to eliminate approximately 1,000 roles, targeting about $50 million in annual run-rate cost savings.